(Q47838173)

6 February 2018

title

Quinacrine inhibits the epidermal dendritic cell migration initiating T cell-mediated skin inflammation (English)

1 reference

6 February 2018

0 references

1 reference

Anton V Gorbachev

1

1 reference

6 February 2018

Alexander V Gasparian

2

1 reference

6 February 2018

Katerina V Gurova

3

1 reference

6 February 2018

Andrei V Gudkov

4

1 reference

6 February 2018

Robert L Fairchild

5

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 August 2007

1 reference

6 February 2018

European Journal of Immunology

published in

1 reference

6 February 2018

volume

37

1 reference

6 February 2018

issue

8

1 reference

6 February 2018

page(s)

2257-2267

1 reference

6 February 2018

A stroma-derived defect in NF-kappaB2-/- mice causes impaired lymph node development and lymphocyte recruitment.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

IL-12 augments CD8+ T cell development for contact hypersensitivity responses and circumvents anti-CD154 antibody-mediated inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

CD40 engagement enhances antigen-presenting langerhans cell priming of IFN-gamma-producing CD4+ and CD8+ T cells independently of IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Missing pieces in the NF-kappaB puzzle

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Early molecular events in the induction phase of contact sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Elicitation of delayed allergic skin reactions with haptens; the dependence of elicitation on hapten combination with protein

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Role of nuclear factor-kappaB in the immune system and bone

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Inhibition of functional T cell priming and contact hypersensitivity responses by treatment with anti-secondary lymphoid chemokine antibody during hapten sensitization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Role of cytokines in epidermal Langerhans cell migration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

NF-kappaB at the crossroads of life and death

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Thiol antioxidants block the activation of antigen-presenting cells by contact sensitizers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Effect of quinacrine, a phospholipase A2 inhibitor on stress and chemically induced gastroduodenal ulcers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

The development of contact hypersensitivity in mouse skin is suppressed by tumor promoters

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636708

7 January 2021

Identifiers

DOI

10.1002/EJI.200636708

1 reference

6 February 2018

1 reference

6 February 2018